Disclosure under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulation, 2015 received from Mr. Ravinder Gupta belongs to promoter group regarding sale of his holding.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech informed the stock exchange that Mr. Ravinder Gupta, part of the promoter group, sold 500 equity shares in the open market on September 25, 2025, at Rs. 933.87 per share, totaling Rs. 4,66,935. The sale was executed under a trading plan previously submitted to the exchange on August 5, 2024. His shareholding reduced marginally from 0.073% to 0.067% of the company. The disclosure was made in Form C under the SEBI Insider Trading Regulations.
This is a very small sale (just 500 shares, reducing holding by only 0.006 percentage points) and was pre-disclosed via a trading plan, so it is unlikely to have any meaningful impact on share price or shareholder sentiment.